U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07283185) titled 'Prospective Comparison of the Carbon Footprint of EUS vs MRCP for Evaluation of Suspected Choledocholithiasis' on Dec. 02.
Brief Summary: MRCP and EUS are diagnostically equivalent in detecting CBD stones among patients with intermediate risk, as shown in a landmark RCT (Jagtap et al., Gut 2022). However, MRI-based imaging is power-intensive, requiring large infrastructure and long scan durations. EUS, a less energy-consuming and portable procedure, has the added advantage of enabling same-session ERCP, reducing the need for repeat procedures.
Study Start Date: Dec., 2025
Study Type: OBSERVATIONAL
Condition:
Choledocholithiasis...